Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The intraocular route of drug administration enables the delivery of high concentrations of therapeutic drugs, while minimizing their systemic absorption. Several drugs are administered into the anterior chamber or vitreous, and the intraocular injection has been effective in curing various intraocular diseases. Rabbit eyes have been widely used for ophthalmic research, as the animal is easy to handle and economical compared to other mammals, and the size of a rabbit eye is similar to that of a human eye. Using a 30 G needle, drugs can be injected into the intracameral and intravitreal spaces of rabbit eyes. The eyeballs are then frozen until analysis, and can be divided into the aqueous humor, vitreous, and retina/choroid. The vitreous and retina/choroid samples can be homogenized and solubilized before analysis. Then, immunoassays can be performed to measure the concentrations of intraocular drugs in each compartment. Appropriate pharmacokinetic models can be used to calculate several parameters, such as the half-life and maximum concentration of the drug. Rabbit eyes can be a good model for pharmacokinetic studies of intraocular drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This enrichment highlights the rabbit’s known ocular sensitivity and its established role as a preclinical model for ocular toxicity assessment, especially in biologic drug development (Ahn et al., 2016; Bussing and Shah, 2020; Sokolowski et al., 2024).”
From A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics (2026) · cites this paper as Ahn et al., 2016
Citations
Cites
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
The Diabetic Retinopathy Clinical Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414264 · Cited by 1,607
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
Brown, D. M., Campochiaro, P. A., Singh, R. P., Li, Z., Gray, S., Saroj, N., Rundle, A. C., Rubio, R. G., & Murahashi, W. Y. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.022 · Cited by 1,155
Boyer, D. S., Yoon, Y. H., Belfort, R., Bandello, F., Maturi, R. K., Augustin, A. J., Li, X.-Y., Cui, H., Hashad, Y., & Whitcup, S. M. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.04.024 · Cited by 1,122
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Campochiaro, P. A., Brown, D. M., Awh, C. C., Lee, S. Y., Gray, S., Saroj, N., Murahashi, W. Y., & Rubio, R. G. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.038 · Cited by 711
Haller, J. A., Bandello, F., Belfort, R., Blumenkranz, M. S., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y. H., Jiao, J., Li, X.-Y., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.05.014 · Cited by 673
RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW
JAGER, R. D., AIELLO, L. P., PATEL, S. C., & CUNNINGHAM, E. T. (2004) · Retina · doi:10.1097/00006982-200410000-00002 · Cited by 572
Pharmacokinetics of Intravitreal Ranibizumab (Lucentis)
Bakri, S. J., Snyder, M. R., Reid, J. M., Pulido, J. S., Ezzat, M. K., & Singh, R. J. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.09.012 · Cited by 541
Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration
Gaudreault, J., Fei, D., Rusit, J., Suboc, P., & Shiu, V. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0601 · Cited by 501
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 414
A schematic eye for the rabbit
Hughes, A. (1972) · Vision Research · doi:10.1016/0042-6989(72)90143-5 · Cited by 391
A schematic eye for the mouse, and comparisons with the rat
Remtulla, S., & Hallett, P. E. (1985) · Vision Research · doi:10.1016/0042-6989(85)90076-8 · Cited by 386
Aqueous humor dynamics in the aging human eye
Toris, C. B., Yablonski, M. E., Wang, Y.-L., & Camras, C. B. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(98)00436-x · Cited by 371
Drug delivery for posterior segment eye disease.
Geroski, D. H., & Edelhauser, H. F. (2000) · PubMed · Cited by 342
Ghate, D., & Edelhauser, H. F. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.275 · Cited by 329
INTRAVITREAL INJECTION TECHNIQUE AND MONITORING: Updated Guidelines of an Expert Panel
Avery, R. L., Bakri, S. J., Blumenkranz, M. S., Brucker, A. J., Cunningham, E. T., D'Amico, D. J., Dugel, P. U., Flynn, H. W., Freund, K. B., Haller, J. A., et al. (2014) · Retina · doi:10.1097/iae.0000000000000399 · Cited by 266
Patel, S. R., Berezovsky, D. E., McCarey, B. E., Zarnitsyn, V., Edelhauser, H. F., & Prausnitz, M. R. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9872 · Cited by 241
Ocular delivery of macromolecules
Kim, Y. C., Chiang, B., Wu, X., & Prausnitz, M. R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.043 · Cited by 232
del Amo, E. M., & Urtti, A. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.05.003 · Cited by 231
Hughes, A. (1979) · Vision Research · doi:10.1016/0042-6989(79)90143-3 · Cited by 222
Review: Practical Issues in Intravitreal Drug Delivery
Maurice, D. (2001) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076801753162807 · Cited by 150
Clearance of Triamcinolone From Vitreous
Scholes, G. N., O'Brien, W. J., Abrams, G. W., & Kubicek, M. F. (1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050100143037 · Cited by 122
Meyer, C. H., Michels, S., Rodrigues, E. B., Hager, A., Mennel, S., Schmidt, J. C., Helb, H.-M., & Farah, M. E. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2010.02064.x · Cited by 120
Intraocular Pharmacokinetics of Ranibizumab in Vitrectomized Versus Nonvitrectomized Eyes
Ahn, S. J., Ahn, J., Park, S., Kim, H., Hwang, D. J., Park, J. H., Park, J. Y., Chung, J. Y., Park, K. H., & Woo, S. J. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-13054 · Cited by 110
Self-citationDurairaj, C., Shah, J. C., Senapati, S., & Kompella, U. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9728-7 · Cited by 91
Pharmacokinetics of Intravitreally Injected Bevacizumab in Vitrectomized Eyes
Ahn, J., Kim, H., Woo, S. J., Park, J. H., Park, S., Hwang, D. J., & Park, K. H. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0009 · Cited by 85
Self-citationLaude, A., Tan, L. E., WILSON, C. G., Lascaratos, G., Elashri, M., Aslam, T. M., Patton, N., & Dhillon, B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.04.003 · Cited by 85
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
Sinapis, Sinapis, C. I., Sinapis, D. I., Routsias, J. G., Pantopoulou, A., Baltatzis, S., Patsouris, E., & Perrea, D. (2011) · Clinical Ophthalmology · doi:10.2147/opth.s19555 · Cited by 82
Christoforidis, J. B., Carlton, M. M., Knopp, M. V., & Hinkle, G. H. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6862 · Cited by 63
Hughes, P. M., Krishnamoorthy, R., & Mitra, A. K. (1996) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1996.12.209 · Cited by 56
Sangwan, V., Pearson, P. A., Paul, H., & Comstock, T. L. (2014) · Ophthalmology and Therapy · doi:10.1007/s40123-014-0027-6 · Cited by 51
Park, S. J., Oh, J., Kim, Y., Park, J.-H., Park, J. Y., Hong, H. K., Park, K. H., Lee, J.-W., Kim, H., Chung, J., et al. (2015) · Eye · doi:10.1038/eye.2014.329 · Cited by 51
Self-citationPharmacokinetics and safety of intravitreally delivered etanercept
Fauser, S., Kalbacher, H., Alteheld, N., Koizumi, K., Krohne, T. U., & Joussen, A. M. (2004) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-004-0895-x · Cited by 46
Clearance of Intravitreal Moxifloxacin
Iyer, M. N., He, F., Wensel, T. G., Mieler, W. F., Benz, M. S., & Holz, E. R. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1124 · Cited by 41
Fluocinolone Acetonide Intravitreal Implant (Iluvien®)
Sanford, M. (2013) · Drugs · doi:10.1007/s40265-013-0010-x · Cited by 40
Bajwa, A., Aziz, K., & Foster, C. S. (2014) · Retina · doi:10.1097/iae.0000000000000239 · Cited by 21
Št́astná, M., Behrens, A., McDonnell, P. J., & Eyk, J. E. V. (2011) · Proteome Science · doi:10.1186/1477-5956-9-8 · Cited by 19
Intraocular Kinetics of Ceftazidime (Modacin ® )
Mochizuki, K., Yamashita, Y., Torisaki, M., Komatsu, M., Tanahashi, T., & Kawasaki, K. (2009) · Ophthalmic Research · doi:10.1159/000267161 · Cited by 15
The optically determined corneal and anterior chamber volumes of the cynomolgus monkey
Greenbaum, S., Lee, P.-Y., Howard-Williams, J., & Podos, S. M. (1985) · Current Eye Research · doi:10.3109/02713688509000849 · Cited by 11
Measurement method of the anterior chamber volume by image analysis.
Kondo, T., Miura, M., & Imamichi, M. (1986) · British Journal of Ophthalmology · doi:10.1136/bjo.70.9.668 · Cited by 9
Research works printed but not linked: 4
- Barza, M. Animal models in evaluation of chemotherapy of ocular infections. In: Zak O, Sande MA, eds. Experimental Models in Antimicrobial Chemotherapy. 187-211 Harcourt Brace Jovanovich, (1986).
- Maurice, D. M., Mishima, S. Ocular pharmacokinetics. Vol. 69 Springer Verlag, (1984).
- Ruby, A. J., Williams, G. A., Blumenkranz, M. S. Vitreous humor. In: Foundations of Clinical Ophthalmology. Lippincott Williams & Wilkins, (2006).
- Jaffe, G. J., Ashton, P., Andrew, P. Intraocular Drug Delivery. Taylor & Francis, (2006). · doi:10.3109/9781420016505
Cited by
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 277
“In addition, Restasis ® (CsA), Eysuvis ® (loteprednol eta-bonate), Lacrisek ® (vitamin A palmitate and vitamin E), Cyclokat ® (CsA) and Artelac Rebalance ® (vitamin B12) are also used for the therapy of DED [22, 23].”
BackgroundOcular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Kim, H. M., & Woo, S. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010108 · Cited by 198
Self-citationChallenges and opportunities for drug delivery to the posterior of the eye
Cabrera, F. J., Wang, D. C., Reddy, K., Acharya, G. S., & Shin, C. S. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.035 · Cited by 133
“However, rabbit eyes produce more mucus, blink less, and produce fewer tears compared with human eyes [14,64].”
BackgroundOcular Delivery of Therapeutic Proteins: A Review
Shastri, D. H., Silva, A. C., & Almeida, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010205 · Cited by 59
Shen, Y., Sun, J., & Sun, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01838-x · Cited by 49
Metadata
- Authors
- Ahn, S. J., Hong, H. K., Na, Y. M., Park, S. J., Ahn, J., Oh, J., Chung, J. Y., Park, K. H., & Woo, S. J.
- Affiliations
- Seoul National University (KR)
- Seoul National University Bundang Hospital (KR)
- Seoul National University Hospital (KR)
- Venue
- Journal of Visualized Experiments
- Publisher
- MyJove Corporation
- Published
- 2016-07-23
- Issue
- 113
- ISSN
- 1940-087X (ISSN-L)
- PMC
- PMC5091672
- OpenAlex
- W2476883165
- Cited by
- 60
- References
- 42
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 13 · 2022: 6 · 2021: 9 · 2020: 7 · 2019: 1 · 2018: 4 · 2017: 1
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Visualized Experiments (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Seoul National University Bundang Hospital
- Seoul National University Hospital
- National Research Council of Science and Technology
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- rabbit eye, intraocular drug delivery, pharmacokinetics, intravitreal injection, intracameral injection, vitreous humor, aqueous humor, pharmacokinetic modeling, ocular drug concentration
- MeSH terms
- Animals, Aqueous Humor, Choroid, Pharmaceutical Preparations, Humans, Pharmacokinetics, Rabbits, Retina, Vitreous Body, Injections, Intraocular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.